Serious gaming as potential training tool for recognition of adverse drug reactions: side-effect exposure—medical education (SeeMe)
-
Published:2024-08-19
Issue:
Volume:
Page:
-
ISSN:0031-6970
-
Container-title:European Journal of Clinical Pharmacology
-
language:en
-
Short-container-title:Eur J Clin Pharmacol
Author:
Bergs Ingmar, Bell LauraORCID, Fedrowitz Sebastian, Krüger Tim, Lemos MartinORCID, Stingl Julia C., Just Katja S.ORCID
Abstract
Abstract
Purpose
The recognition of adverse drug reactions (ADRs) is an important part of daily clinical work. However, medical education in this field is mostly drug-based and does not address adequately the complexity of this field regarding individual risk factors and polypharmacy. This study investigates the potential of the web-based serious game SeeMe (side-effect exposure—medical education) in pharmacological education of medical students to improve the recognition of relevant ADRs.
Methods
One hundred fifty-seven medical students were recruited to evaluate the serious game SeeMe. SeeMe was developed to improve knowledge and recognition of ADRs in clinical practice. Players take on the role of a physician trying to understand fictional patients with ADRs. Before and after an 8-week playing period, an evaluation was carried out through a pre- and post-questionnaire and a pre- and post- knowledge test.
Results
The students achieved significantly better results in the knowledge test, as almost twice as many exam-relevant questions were answered correctly (p < 0.001). The serious game had a positive effect on the students’ perception of the importance of ADRs.
Conclusion
This study demonstrates the potential of web- and case-based fictional serious games in medical education. The improved recognition of side effects represents a crucial step for education and training in clinical pharmacology. Future versions of the serious game may take this further and focus on training in the treatment of ADRs and their relevance in various healthcare professions.
Funder
European Community’s Horizon 2020 Programme Exploratory Teaching Space Innovation In Higher Education Foundation Universitätsklinikum RWTH Aachen
Publisher
Springer Science and Business Media LLC
Reference29 articles.
1. Just KS, Dormann H, Schurig M, Böhme M, Steffens M, Plank-Kiegele B, Ettrich K, Seufferlein T, Gräff I, Igel S et al (2020) The phenotype of adverse drug effects: do emergency visits due to adverse drug reactions look different in older people? Results from the ADRED study. Br J Clin Pharmacol 86:2144–2154 2. Just KS, Dormann H, Böhme M, Schurig M, Schneider KL, Steffens M, Dunow S, Plank-Kiegele B, Ettrich K, Seufferlein T et al (2020) Personalising drug safety—results from the multi-centre prospective observational study on adverse drug reactions in emergency departments (ADRED). Eur J Clin Pharmacol 76:439–448 3. Just KS, Dormann H, Schurig M, Böhme M, Fracowiak J, Steffens M, Scholl C, Seufferlein T, Gräff I, Schwab M, Stingl JC (2020) Adverse drug reactions in the emergency department: is there a role for pharmacogenomic profiles at risk?-Results from the ADRED study. J Clin Med 9(6):1801 4. Swen JJ, van der Wouden CH, Manson LEN, Abdullah-Koolmees H, Blagec K, Blagus T, Böhringer S, Cambon-Thomsen A, Cecchin E, Cheung K-C et al (2023) A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study. The Lancet 401:347–356 5. Schurig AM, Bohme M, Just KS, Scholl C, Dormann H, Plank-Kiegele B, Seufferlein T, Graff I, Schwab M, Stingl JC (2018) Adverse drug reactions (ADR) and emergencies. Dtsch Arztebl Int 115:251–258
|
|